描述：MediLumine 代理，MediLumine 上海代理，MediLumine 北京代理， MediLumine 總代理, MediLumine 一級(jí)代理， MediLumine 特約代理上海起發(fā)實(shí)驗(yàn)試劑有限公司 MediLumine 專業(yè)代理，具體產(chǎn)品信息歡迎電詢：4006551678
世界*實(shí)驗(yàn)材料供應(yīng)商 MediLumine 正式授權(quán)上海起發(fā)為其中國(guó)代理， MediLumine 在一直是行業(yè)的*,一直為廣大科研客戶提供zui為優(yōu)質(zhì)的產(chǎn)品和服務(wù),上海起發(fā)一直秉承為中國(guó)科研客戶帶來的產(chǎn)品，的服務(wù)，簽約 MediLumine 就是為了給廣大科研客戶帶來更加完善的產(chǎn)品和服務(wù),您的滿意將是我們zui大的收獲
MediLumine 中國(guó)代理, MediLumine 上海代理， MediLumine 北京代理，MediLumine 廣東代理，MediLumine 江蘇代理MediLumine 湖北代理,MediLumine 天津,MediLumine 黑龍江代理,MediLumine 內(nèi)蒙古代理,MediLumine 吉林代理,MediLumine 福建代理, MediLumine 江蘇代理, MediLumine 浙江代理, MediLumine 四川代理,
MediLumine（發(fā)音為? m?dilu 分鐘）是臨床前小動(dòng)物造影劑用于顯微CT成像的*的供應(yīng)商。我們的Fenestra®和Mvivo™造影劑用于廣泛的應(yīng)用，如肝臟疾病（如糖尿病，脂肪肝疾病，肝轉(zhuǎn)移）的檢測(cè)，分期和監(jiān)測(cè)以及血管生成或心血管疾病研究的血管成像。
我們使用專有的脂質(zhì)，聚合物，多糖，水凝膠和納米顆粒技術(shù)的CRO配方開發(fā)服務(wù)使我們成為成像，藥理學(xué)和藥物傳遞研究的*合作伙伴。
Fenestra® is a licensed technology that solves several key problems associated with micro-CT imaging. This biochemically activated emulsion is comprised of iodinated lipids that provide contrast enhancement and a novel oil-in-water lipid emulsion that selectively localizes the lipids for small animal imaging. The unique Fenestra® formulation is biodegradable and compley eliminated by hepatocyte metabolism.
Mvivo™ is our nanoparticle contrast agent line of products for in-vivo imaging. These contrast agents are are ideal for applications such as targeted imaging, vascular and tumor imaging, techniques that require high resolution contrast agents to match the higher resolution preclinical imaging modalities:
Based on a proprietary sequence of natural and unnatural amino acids, the biostable B1R agonist for blood brain tumor barrier (BBTB) permeabilization, B2R for general blood brain barrier permeabilization and B1R/B2R agonist for optimum BBTB/BBB permeabilization are available exclusively through MediLumine. MediLumine offers three different peptide agonists which are ideal for co-injection with other contrast agents and possible therapeutic compounds to cross the blood brain barrier.
These agonists can also be used for other applications since recent publications have shown that they are expressed in other disease states.
MediLumine™ offers accessories and high quality hardware solutions for challenging aspects of preclinical in vivo research such as control/maintenance of animal body temperature during experimental surgery, high quality anesthesia and performing successful tail vein injection:
| Product: | Fenestra® VC |
| Composition: | 1,3-bis-[7-(3-amino-2,4,6-triiodophenyl)-heptanoyl]-2-oleoyl glycerol (DHOG) in a 20% (w/v) total triglyceride oil-in-water pegylated emulsion with 10% DHOG (nominal 50 mg I/mL) |
| Description: | Fenestra VC contrast agent is used for preclinical angiography, liver and spleen imaging of small animals. It is a specialized version of Fenestra LC in which the surface of the lipid emulsion particles is modified with DSPE-PEG so as to alter the recognition of the particle by the receptors on hepatocytes that are responsible for its uptake into the liver. With Fenestra VC, the delayed uptake by liver cells produces an agent with superior blood pool imaging properties that last for several hours after injection. Like its liver-selective counterpart, Fenestra VC is eventually metabolized and eliminated through the hepatobiliary system. |
| Application: | Quantitation of metastatic tumour burdens in liver, angiography, assessing anti-angiogenesis, 4D Cardiac imaging, soft tissue contrast for multimodal imaging. |
| Disciplines: | Oncology, cardiovascular, drug delivery, imaging research |
| Product: | Fenestra® LC |
| Composition: | 1,3-bis-[7-(3-amino-2,4,6-triiodophenyl)-heptanoyl]-2-oleoyl glycerol (DHOG) in a 20% (w/v) total triglyceride oil-in-water emulsion with 10% DHOG (nominal 50 mg I/mL) |
| Description: | MediLumine’s Fenestra LC provides visualization of the hepatobiliary system by exploiting the endogenous lipid metabolism pathways present in the body. Fenestra LC mimics chylomicron remnant particles and thereby localizes the contrast-producing lipids it contains into the hepatic parenchyma. Because the uptake and clearance profiles of the lipid molecules are determined by the metabolic status of extracellular and intracellular liver lipases, Fenestra LC provides the ability to assess both hepatobiliary anatomy as well as liver function by CT imaging. |
| Application: | Detection, staging, and monitoring of parenchymal liver diseases, Quantitation of metastatic tumour burdens in soft tissues, soft tissue contrast for multimodal imaging. |
| Disciplines: | Diabetes, Fatty Liver Disease, Oncology, Drug Discovery & Imaging Research |
我們公司zui大優(yōu)勢(shì)是強(qiáng)大的采購(gòu)，
1：基本什么都能進(jìn)口，血清，抗體，耗材，還有部分限制進(jìn)口的，
2：貨品全，現(xiàn)經(jīng)營(yíng)過700多個(gè)品牌，基本所有生物試劑耗材都可以進(jìn)口，特別是冷偏的產(chǎn)品那就更有優(yōu)勢(shì)，
3：提供加急服務(wù)，一般1-2周到貨，超過時(shí)限加急費(fèi)全免
4：價(jià)格公道，絕大部分價(jià)格有優(yōu)勢(shì)，當(dāng)然不能保證100%產(chǎn)品都是,因?yàn)橐馕吨鴽]有服務(wù).
5：良好的信譽(yù)，大部分客戶我們提供貨到付款服務(wù)，客戶包括清華，北大 交大 復(fù)旦，中山等100多所大學(xué)，ROCHE，阿斯利康，國(guó)藥 ，fisher等500多家公司
6：我們還是Santa,Advanced Biotechnologies Inc, MediLumine,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. Dako,Inc, GePromegaridege,MediLumine Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,MediLumine , Polysciences,prospecbi, QA-BIO,quickzyme,FULLERLABS,INC,sterlitech；sysy,TriLink BioTechnologies,Inc；worthington-biochem,zyagen等幾十家國(guó)外公司授權(quán)代理。
7：我們還是invitrogen,qiagen,Midland BioProducts Corporationam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等知名*批發(fā)，歡迎合作。
上海起發(fā)實(shí)驗(yàn)試劑有限公司
：
辦公：
:
地址：上海市浦東新區(qū)晨陽(yáng)路225弄東方現(xiàn)代商業(yè)廣場(chǎng)46號(hào)303室(近東亭路)
